STXBP6
Syntaxin-binding protein 6
Also known as: amisyn, HSPC156, STXB6_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8NFX7
- Gene
- STXBP6
- Ensembl
- ENSG00000168952
- Chromosome
- 14
- Canonical length
- 210 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
Enables cadherin binding activity involved in cell-cell adhesion. Predicted to be involved in negative regulation of exocytosis. Located in adherens junction. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
210 residues, UniProt reviewed canonical sequence.
>Q8NFX7|STXBP6
1 MSAKSAISKE IFAPLDERML GAVQVKRRTK KKIPFLATGG QGEYLTYICL SVTNKKPTQA
61 SITKVKQFEG STSFVRRSQW MLEQLRQVNG IDPNGDSAEF DLLFENAFDQ WVASTASEKC
121 TFFQILHHTC QRYLTDRKPE FINCQSKIMG GNSILHSAAD SVTSAVQKAS QALNERGERL
181 GRAEEKTEDL KNSAQQFAET AHKLAMKHKCLocalizationUniProt · AlphaFold · HPA
Whether an antibody against STXBP6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 40 nTPM
Expression across tissuesHPA
Tissue
- placenta: 40 nTPM
- pancreas: 37 nTPM
- epididymis: 36 nTPM
- lung: 24 nTPM
- heart muscle: 23 nTPM
- basal ganglia: 22 nTPM
Single-cell type
- mast cells: 462 nCPM
- pancreatic acinar cells: 371 nCPM
- melanocytes: 357 nCPM
- goblet cells: 299 nCPM
- epididymal clear cells: 298 nCPM
- oligodendrocytes: 260 nCPM
Immune cell
- gdT-cell: 1.1 nTPM
- plasmacytoid DC: 0.6 nTPM
- naive CD8 T-cell: 0.4 nTPM
- MAIT T-cell: 0.2 nTPM
- total PBMC: 0.2 nTPM
- memory CD4 T-cell: 0.1 nTPM
Brain region
- thalamus: 95 nTPM
- cerebral cortex: 65 nTPM
- medulla oblongata: 58 nTPM
- midbrain: 57 nTPM
- hypothalamus: 53 nTPM
- basal ganglia: 48 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.18
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.71
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Exocyst complex component Sec3, PIP2-binding N-terminal domain
- v-SNARE, coiled-coil homology domain
- Synaptobrevin
- Exocyst complex component SEC3 N-terminal PIP2 binding PH
- Syntaxin-binding protein 6, PH domain
- STXBP6, SNARE domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of STXBP6 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads STXBP6 as an antibody target. Whether an autoantibody or antibody against STXBP6 could matter depends on whether native STXBP6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
STXBP6 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label STXBP6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...